
    
      The safety profile of ODM-204 will be explored together with the pharmacokinetics,
      pharmacodynamics and tumour response to treatment with ODM-204 to recommend the dosing
      regimen for further clinical studies. The pharmacokinetic properties of ODM-204 will be
      evaluated after single and multiple dose administrations at different dose levels.
    
  